Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OCS-01 in Diabetic Macular Edema
NCT06172257Phase 3Completed
- Sponsor
- Oculis
- Start
- Mar 2024
- Primary completion
- Apr 2026
- Modality
- Orthosteric Ligands
- Countries
- 4
01
Overview
A Phase 3 trial of dexamethasone in diabetic macular edema (DME), sponsored by Oculis. Started Mar 2024; status: completed.
02
Drugs
dexamethasone
03
Conditions
diabetic macular edema (DME)
Beyond the preview
Go deeper on NCT06172257.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06172257.